ESR1 and breast carcinoma: Palbociclib or VT02956 treatment alone inhibited the colony-formation of ER+ breast cancer cells, whereas the combination of palbociclib and VT02956 resulted in a much more drastic reduction in colony formation (Fig. 6d and Supplementary Fig. 8j).